The Effects of Beta-Diethylaminoethyl-Diphenylpropylacetate (SKF-525-A) on Sickling in vitro
Abstract
Beta-diethylaminoethyl-diphenylpropylacetate (SKF-525-A), a surface- active agent, inhibits sickling of erythrocytes from individuals with homozygous sickle cell anemia (SS cells) in vitro. Sickling was prevented when SS cells were incubated in .0003 M SKF-525-A, washed free of excess drug, and then deoxygenated in humidified nitrogen atmosphere. Polymerization of sickle hemoglobin and submembrane vesicles could be demonstrated in these cells by electron microscopy. At .0003 M SKF-525-A approximately 10% of the cells lysed. Incubation of pretreated cells at 37C without added oxygen for 24 hours did not produce significant additional lysis. Irreversibly sickled cells were unaffected by drug treatment. Preliminary studies suggest that the oxygen affinity of sickle hemoglobin in the intact cell is not altered by SKF-525-A. It is hypothesized that inhibition of sickling is the result of drug-induced alterations of the cell membrane.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 01, 1974
- Accession Number
- AD0776393
Entities
People
- Dale H. Heitkamp
- Kenneth Mills
- Priscilla A. Gilman
- Vincent F. Garry Jr.